BackIN8bio Overview

IN8bio Total Liabilities

Track IN8bio's total liabilities ($3.5M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$3.48M
↓ 41.86% YoYΔ $-2.51M vs prior year quarter

Peer average

Loading

IN8bio Total Liabilities History

Loading

IN8bio vs. peers: Total Liabilities Comparison

Loading

IN8bio Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

IN8bio (INAB) FAQ

IN8bio (INAB) currently reports a total liabilities of $3.5M as of March 2026. That compares with $6M in the prior-year period — down 41.9% year over year. Use the charts on this page to explore IN8bio's total liabilities history and peer comparisons.

IN8bio's total liabilities decreased from $6M to $3.5M — a 41.9% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

IN8bio reported $3.5M in total liabilities as of March 2026. That compares with $6M in the prior-year period — down 41.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $3.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for IN8bio, and consider following INAB for alerts when major investors trade the stock.

IN8bio is classified in the Healthcare sector. On total liabilities, it currently shows $3.5M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing INAB with unrelated industries.